arXiv subjects

Timurhan Cebeci

Publications and source records attributed to Timurhan Cebeci.

3 recordsLinked to original sources

arXiv2025

Cyst-X: A Multi-Center MRI Benchmark and Federated Learning Framework for Malignancy-Risk Stratification of Pancreatic Cystic Neoplasm

Pancreatic cancer is projected to be the second-deadliest cancer by 2030, making early detection critical. Intraductal papillary mucinous neoplasms (IPMNs), key cancer precursors, present a clinical dilemma, as current guidelines struggle to stratify malignancy risk, leading to unnecessary surgeries or missed diagnoses. Here, we introduce Cyst-X, a multi-center MRI benchmark and a federated learning framework for IPMN malignancy-risk stratification. The dataset comprises 1,461 abdominal MRI scans from 764 patients at seven international centers, with three-tier malignancy labels anchored in histopathology or three-year imaging follow-up and expert pancreas segmentations. The pipeline couples the PanSegNet pancreas segmenter with a 3D DenseNet-121 classifier and a parallel radiomics predictor. On internal cross-validation, the deep learning classifier reached a mean area under the receiver operating characteristic curve (AUC) of 0.85 (95% confidence interval 0.84-0.86) on T2-weighted MRI for high-risk versus low- or no-risk discrimination, with the average precision rising from a prevalence baseline of 0.23 to 0.64. This performance was preserved (AUC 0.85, FedProx) when training was distributed across institutions without exchange of raw patient images. Benchmarked against three blinded radiologists on a 629-case reader subset evaluated under imaging-only conditions, the classifier matched or exceeded sensitivity at comparable specificity. To accelerate research in early pancreatic cancer detection, we publicly release the Cyst-X dataset, segmentation masks, and trained models as the first large-scale, multi-centre MRI resource for pancreatic cystic neoplasm analysis.

eess.IV↗

arXiv2024

Large Scale MRI Collection and Segmentation of Cirrhotic Liver

Liver cirrhosis represents the end stage of chronic liver disease, characterized by extensive fibrosis and nodular regeneration that significantly increases mortality risk. While magnetic resonance imaging (MRI) offers a non-invasive assessment, accurately segmenting cirrhotic livers presents substantial challenges due to morphological alterations and heterogeneous signal characteristics. Deep learning approaches show promise for automating these tasks, but progress has been limited by the absence of large-scale, annotated datasets. Here, we present CirrMRI600+, the first comprehensive dataset comprising 628 high-resolution abdominal MRI scans (310 T1-weighted and 318 T2-weighted sequences, totaling nearly 40,000 annotated slices) with expert-validated segmentation labels for cirrhotic livers. The dataset includes demographic information, clinical parameters, and histopathological validation where available. Additionally, we provide benchmark results from 11 state-of-the-art deep learning experiments to establish performance standards. CirrMRI600+ enables the development and validation of advanced computational methods for cirrhotic liver analysis, potentially accelerating progress toward automated Cirrhosis visual staging and personalized treatment planning.

eess.IV↗

arXiv2024

Towards Synergistic Deep Learning Models for Volumetric Cirrhotic Liver Segmentation in MRIs

Liver cirrhosis, a leading cause of global mortality, requires precise segmentation of ROIs for effective disease monitoring and treatment planning. Existing segmentation models often fail to capture complex feature interactions and generalize across diverse datasets. To address these limitations, we propose a novel synergistic theory that leverages complementary latent spaces for enhanced feature interaction modeling. Our proposed architecture, nnSynergyNet3D integrates continuous and discrete latent spaces for 3D volumes and features auto-configured training. This approach captures both fine-grained and coarse features, enabling effective modeling of intricate feature interactions. We empirically validated nnSynergyNet3D on a private dataset of 628 high-resolution T1 abdominal MRI scans from 339 patients. Our model outperformed the baseline nnUNet3D by approximately 2%. Additionally, zero-shot testing on healthy liver CT scans from the public LiTS dataset demonstrated superior cross-modal generalization capabilities. These results highlight the potential of synergistic latent space models to improve segmentation accuracy and robustness, thereby enhancing clinical workflows by ensuring consistency across CT and MRI modalities.

cs.CV↗